Treace Medical Concepts Inc (TMCI)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. John T. TreaceFounder, Chairman & CEO | 50.00k | 177.92k | 買い | 3.56 | 12.65M | 0.40% |
| 2026-05-12 | Mr. John T. TreaceFounder, Chairman & CEO | 153.76k | 375.51k | 買い | 2.17 - 2.62 | 11.94M | 1.30% |
| 2026-04-17 | Mr. Mark L. HairCFO | -11.55k | 0.00 | Sale to Issuer | - | 165.31k | -6.53% |
| 2026-03-08 | Mr. Scot M. ElderChief Legal & Compliance Officer and Corporate Secretary | -1.85k | 0.00 | Sale to Issuer | - | 161.06k | -1.14% |
| 2026-03-08 | Mr. John T. TreaceFounder, Chairman & CEO | -7.08k | 0.00 | Sale to Issuer | - | 11.79M | -0.06% |
| 2026-03-08 | Mr. Mark L. HairCFO | -4.66k | 0.00 | Sale to Issuer | - | 151.86k | -2.98% |
| 2026-03-08 | Dr. Sean F. ScanlanChief Innovation & Marketing Officer | -1.80k | 0.00 | Sale to Issuer | - | 200.76k | -0.89% |
| 2026-02-10 | Dr. Sean F. ScanlanChief Innovation & Marketing Officer | 16.88k | 17.72k | Derivative Exercise and Retained Stock | 1.05 | 195.18k | 9.46% |
| 2026-01-22 | Mr. John T. TreaceFounder, Chairman & CEO | -14.25k | 0.00 | Sale to Issuer | - | 11.76M | -0.12% |
| 2026-01-21 | Dr. Sean F. ScanlanChief Innovation & Marketing Officer | 53.50k | 38.52k | Derivative Exercise and Retained Stock | 0.72 | 178.31k | 42.87% |
| 2026-01-22 | Mr. Mark L. HairCFO | -17.04k | 0.00 | Sale to Issuer | - | 142.07k | -10.71% |
| 2026-01-22 | Mr. Scot M. ElderChief Legal & Compliance Officer and Corporate Secretary | -9.45k | 0.00 | Sale to Issuer | - | 155.32k | -5.74% |
| 2026-01-10 | Mr. Mark L. HairCFO | -8.72k | 0.00 | Sale to Issuer | - | 112.24k | -7.21% |
| 2026-01-10 | Mr. John T. TreaceFounder, Chairman & CEO | -13.22k | 0.00 | Sale to Issuer | - | 11.74M | -0.11% |
| 2026-01-10 | Mr. Scot M. ElderChief Legal & Compliance Officer and Corporate Secretary | -4.54k | 0.00 | Sale to Issuer | - | 132.89k | -3.31% |
| 2025-12-01 | Mr. Gaetano M. Guglielminoインサイダー | -22.10k | 0.00 | Sale to Issuer | - | 68.65k | -24.35% |
| 2025-10-25 | Mr. Scot M. ElderChief Legal & Compliance Officer and Corporate Secretary | -984.00 | 0.00 | Sale to Issuer | - | 122.11k | -0.80% |
| 2025-10-24 | Dr. Sean F. ScanlanChief Innovation & Marketing Officer | -208.00 | 0.00 | Sale to Issuer | - | 89.65k | -0.23% |
| 2025-09-30 | Mr. Scot M. ElderChief Legal & Compliance Officer and Corporate Secretary | -16.88k | 0.00 | Sale to Issuer | - | 120.60k | -12.28% |
| 2025-08-09 | Mr. Aaron J. BeruttiSVP of Commercial Excellence | -4.91k | 0.00 | Sale to Issuer | - | 23.14k | -17.50% |
| 2025-08-09 | Dr. Sean F. ScanlanChief Innovation & Marketing Officer | -9.81k | 0.00 | Sale to Issuer | - | 89.01k | -9.93% |
| 2025-08-09 | Mr. Mark L. HairCFO | -22.21k | 0.00 | Sale to Issuer | - | 97.74k | -18.52% |
| 2025-08-09 | Mr. Scot M. ElderChief Legal & Compliance Officer and Corporate Secretary | -10.52k | 0.00 | Sale to Issuer | - | 86.05k | -10.89% |
| 2025-07-18 | Dr. Sean F. ScanlanChief Innovation & Marketing Officer | 33.44k | 24.00k | Derivative Exercise and Retained Stock | 0.72 | 58.52k | 133.29% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。